![Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-88118-6/MediaObjects/41598_2021_88118_Fig7_HTML.png)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig1_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
![Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep30797/MediaObjects/41598_2016_Article_BFsrep30797_Fig1_HTML.jpg)
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking | PLOS ONE
![Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00214/article_deploy/html/images/pharmaceuticals-15-00214-g001.png)
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
![Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist](https://www.naabt.org/images/tech_2.jpg)
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
![Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/51f6c7c2-6754-4555-bfa0-19aa66bb36a1/b1_lrg.jpg)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
![Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances](https://www.science.org/cms/10.1126/sciadv.aax9115/asset/444fb070-f156-49ca-bb7a-06de580c94d4/assets/graphic/aax9115-f1.jpeg)
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
![Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3ee6606b27751656285b7108eac6a5e8030e0439/4-Table1-1.png)
Table 1 from Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors | Semantic Scholar
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig4_HTML.png)